Could Genetically Engineered Humans Become a Reality?
By Robert King,
Washington Examiner
| 04. 30. 2015
[Quotes CGS's Marcy Darnovsky]
Untitled Document
Science is closer to creating genetically engineered human beings, and the advances in technology are sparking ethical arguments over making "a new kind of person."
The National Institutes of Health said Wednesday it would not fund any research into the gene editing of human embryos. The decision comes after Chinese researchers announced last week results from the first study to edit human embryo genes.
Gene editing, as the term implies, enables a scientist to cut DNA from a genome and insert it into another genome.
Theoretically an edited human embryo could then be implanted in a woman's uterus.
The goal is to edit the group of cells called the germline that could hand down diseases from one generation to the next. Researchers hope to prevent inherited diseases such as cystic fibrosis or sickle cell anemia from being passed on from a parent to a child.
The Chinese study was not successful. Scientists missed targets to place the DNA and discovered unknown mutations to cells.
However, the experiment has renewed talk in the scientific community of whether such research...
Related Articles
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...